Brain metastasis (BM) is more common in EGFR-mutant non-small cell lung cancer (NSCLC) than in wild-type NSCLC [3], and the prognosis is poor if patients develop BM [4, 5]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.